Regulation - Regulation, Nephrology and Hepatology, Cardio-vascular

US FDA accepts NDAs for Otsuka's tolvaptan and BTG's Varisolve

12-04-2013

Japanese mid-sized drugmaker Otsuka Pharmaceutical (TYO: 4578) says that the US Food and Drug Administration…

BTGCardio-vascularNephrology and HepatologyNorth AmericaOtsukaPharmaceuticalRare diseasesRegulationtolvaptanVarisolve

New uses of Cialis, Votubia, Galvus, Eucreas and Eliquis backed by CHMP, but not Qsiva

24-09-2012

Among a batch of recommendations resulting in meetings last week from the European Medicines Agency's…

Bristol-Myers SquibbCardio-vascularCialisDiabetesEli LillyEliquisEucreasEuropeGalvusMen's HealthMetabolicsNephrology and HepatologyNovartisPharmaceuticalQsivaQsymiaRegulationVivusVotubia

COMPANY SPOTLIGHT

Parexel

Parexel

Back to top